Structural requirements of simple organic cations for recognition by multidrug-resistant cells
We previously noted that a wide variety of drugs which are recognized by multidrug-resistant cells (MDR+) are positively charged. However, it remains unclear why and how such a large number of structurally different compounds can be distinguished by MDR+ cells. The majority of the diverse compounds...
Gespeichert in:
Veröffentlicht in: | Cancer research (Chicago, Ill.) Ill.), 1992-11, Vol.52 (22), p.6385-6389 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6389 |
---|---|
container_issue | 22 |
container_start_page | 6385 |
container_title | Cancer research (Chicago, Ill.) |
container_volume | 52 |
creator | DELLINGER, M PRESSMAN, B. C CALDERON-HIGGINSON, C SAVARAJ, N TAPIERO, H KOLONIAS, D LAMPIDIS, T. J |
description | We previously noted that a wide variety of drugs which are recognized by multidrug-resistant cells (MDR+) are positively charged. However, it remains unclear why and how such a large number of structurally different compounds can be distinguished by MDR+ cells. The majority of the diverse compounds subject to MDR are complex and thereby complicate definitive structure/function characterization of the P-glycoprotein-mediated MDR mechanism. Using a series of simple aromatic (alkypyridiniums) and nonaromatic (alkylguanidiniums) organic cations differing in their lipophilicity by stepwise additions of single alkyl carbons, we demonstrate by growth inhibition studies that a single aromatic moiety and a critical degree of lipophilicity (log P > -1) are required for recognition of these simple organic cations by MDR+ cells. Thus, MDR+ cells are not cross-resistant to the nonaromatic guanidiniums but do show cross-resistance to those aromatic pyridiniums with chain lengths > four. Resistance ratios, as determined by comparison of 50% inhibitory doses in MDR- versus MDR+ cells, increase as a function of increasing chain lengths of these latter simple aromatic compounds. Resistance to pyridinium analogues in MDR+ cells is reversible by co-treatment with nontoxic doses of verapamil. Preliminary uptake data with radioactive analogues further implicate the MDR mechanism of lowered drug accumulation in accounting for resistance to the pyridinium homologues. Utilization of these simple organic cations provides a rational basis for better defining the physical chemical properties of more complex compounds processed by the MDR mechanism and suggests a strategy for designing chemotherapeutic agents with reduced susceptibility to MDR. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73283248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73283248</sourcerecordid><originalsourceid>FETCH-LOGICAL-h269t-404fd31dd8bbbd68f417ea419e266aa40564fe5df739f0770d1138539fed28813</originalsourceid><addsrcrecordid>eNo9kEtLAzEUhYMotVZ_gpCFuBtIJskkXUrxBQUX6tYhk0eNZJI2j0X_vVMcXF3OPR_nXO4ZWGJGRMMpZedgiRASDaO8vQRXOf9MkmHEFmCBCROUkCX4ei-pqlKT9DCZQ3XJjCaUDKOF2Y17b2BMOxmcgkoWF0OGNqYJVXEX3GkBhyMcqy9Op7prkskuFxkKVMb7fA0urPTZ3MxzBT6fHj82L8327fl187BtvttuXRqKqNUEay2GYdCdsBRzIylem7brpKSIddQapi0na4s4RxpjItgkjG6FwGQF7v9y9ykeqsmlH10-XSCDiTX3nLSCtFRM4O0M1mE0ut8nN8p07OeHTP7d7MuspLdJBuXyP0Yppmjq_gUCrmvX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73283248</pqid></control><display><type>article</type><title>Structural requirements of simple organic cations for recognition by multidrug-resistant cells</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>American Association for Cancer Research</source><creator>DELLINGER, M ; PRESSMAN, B. C ; CALDERON-HIGGINSON, C ; SAVARAJ, N ; TAPIERO, H ; KOLONIAS, D ; LAMPIDIS, T. J</creator><creatorcontrib>DELLINGER, M ; PRESSMAN, B. C ; CALDERON-HIGGINSON, C ; SAVARAJ, N ; TAPIERO, H ; KOLONIAS, D ; LAMPIDIS, T. J</creatorcontrib><description>We previously noted that a wide variety of drugs which are recognized by multidrug-resistant cells (MDR+) are positively charged. However, it remains unclear why and how such a large number of structurally different compounds can be distinguished by MDR+ cells. The majority of the diverse compounds subject to MDR are complex and thereby complicate definitive structure/function characterization of the P-glycoprotein-mediated MDR mechanism. Using a series of simple aromatic (alkypyridiniums) and nonaromatic (alkylguanidiniums) organic cations differing in their lipophilicity by stepwise additions of single alkyl carbons, we demonstrate by growth inhibition studies that a single aromatic moiety and a critical degree of lipophilicity (log P > -1) are required for recognition of these simple organic cations by MDR+ cells. Thus, MDR+ cells are not cross-resistant to the nonaromatic guanidiniums but do show cross-resistance to those aromatic pyridiniums with chain lengths > four. Resistance ratios, as determined by comparison of 50% inhibitory doses in MDR- versus MDR+ cells, increase as a function of increasing chain lengths of these latter simple aromatic compounds. Resistance to pyridinium analogues in MDR+ cells is reversible by co-treatment with nontoxic doses of verapamil. Preliminary uptake data with radioactive analogues further implicate the MDR mechanism of lowered drug accumulation in accounting for resistance to the pyridinium homologues. Utilization of these simple organic cations provides a rational basis for better defining the physical chemical properties of more complex compounds processed by the MDR mechanism and suggests a strategy for designing chemotherapeutic agents with reduced susceptibility to MDR.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 1358433</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Animals ; Antineoplastic agents ; ATP-Binding Cassette, Sub-Family B, Member 1 ; Biological and medical sciences ; Cations - pharmacology ; Cell Division - drug effects ; Chemical Phenomena ; Chemistry, Physical ; Drug Resistance - physiology ; General aspects ; Guanidine ; Guanidines - pharmacology ; Humans ; Medical sciences ; Membrane Glycoproteins - physiology ; Pharmacology. Drug treatments ; Pyridinium Compounds - pharmacology ; Structure-Activity Relationship ; Tumor Cells, Cultured - drug effects ; Verapamil - pharmacology</subject><ispartof>Cancer research (Chicago, Ill.), 1992-11, Vol.52 (22), p.6385-6389</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4414011$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1358433$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DELLINGER, M</creatorcontrib><creatorcontrib>PRESSMAN, B. C</creatorcontrib><creatorcontrib>CALDERON-HIGGINSON, C</creatorcontrib><creatorcontrib>SAVARAJ, N</creatorcontrib><creatorcontrib>TAPIERO, H</creatorcontrib><creatorcontrib>KOLONIAS, D</creatorcontrib><creatorcontrib>LAMPIDIS, T. J</creatorcontrib><title>Structural requirements of simple organic cations for recognition by multidrug-resistant cells</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>We previously noted that a wide variety of drugs which are recognized by multidrug-resistant cells (MDR+) are positively charged. However, it remains unclear why and how such a large number of structurally different compounds can be distinguished by MDR+ cells. The majority of the diverse compounds subject to MDR are complex and thereby complicate definitive structure/function characterization of the P-glycoprotein-mediated MDR mechanism. Using a series of simple aromatic (alkypyridiniums) and nonaromatic (alkylguanidiniums) organic cations differing in their lipophilicity by stepwise additions of single alkyl carbons, we demonstrate by growth inhibition studies that a single aromatic moiety and a critical degree of lipophilicity (log P > -1) are required for recognition of these simple organic cations by MDR+ cells. Thus, MDR+ cells are not cross-resistant to the nonaromatic guanidiniums but do show cross-resistance to those aromatic pyridiniums with chain lengths > four. Resistance ratios, as determined by comparison of 50% inhibitory doses in MDR- versus MDR+ cells, increase as a function of increasing chain lengths of these latter simple aromatic compounds. Resistance to pyridinium analogues in MDR+ cells is reversible by co-treatment with nontoxic doses of verapamil. Preliminary uptake data with radioactive analogues further implicate the MDR mechanism of lowered drug accumulation in accounting for resistance to the pyridinium homologues. Utilization of these simple organic cations provides a rational basis for better defining the physical chemical properties of more complex compounds processed by the MDR mechanism and suggests a strategy for designing chemotherapeutic agents with reduced susceptibility to MDR.</description><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>ATP-Binding Cassette, Sub-Family B, Member 1</subject><subject>Biological and medical sciences</subject><subject>Cations - pharmacology</subject><subject>Cell Division - drug effects</subject><subject>Chemical Phenomena</subject><subject>Chemistry, Physical</subject><subject>Drug Resistance - physiology</subject><subject>General aspects</subject><subject>Guanidine</subject><subject>Guanidines - pharmacology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - physiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyridinium Compounds - pharmacology</subject><subject>Structure-Activity Relationship</subject><subject>Tumor Cells, Cultured - drug effects</subject><subject>Verapamil - pharmacology</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtLAzEUhYMotVZ_gpCFuBtIJskkXUrxBQUX6tYhk0eNZJI2j0X_vVMcXF3OPR_nXO4ZWGJGRMMpZedgiRASDaO8vQRXOf9MkmHEFmCBCROUkCX4ei-pqlKT9DCZQ3XJjCaUDKOF2Y17b2BMOxmcgkoWF0OGNqYJVXEX3GkBhyMcqy9Op7prkskuFxkKVMb7fA0urPTZ3MxzBT6fHj82L8327fl187BtvttuXRqKqNUEay2GYdCdsBRzIylem7brpKSIddQapi0na4s4RxpjItgkjG6FwGQF7v9y9ykeqsmlH10-XSCDiTX3nLSCtFRM4O0M1mE0ut8nN8p07OeHTP7d7MuspLdJBuXyP0Yppmjq_gUCrmvX</recordid><startdate>19921115</startdate><enddate>19921115</enddate><creator>DELLINGER, M</creator><creator>PRESSMAN, B. C</creator><creator>CALDERON-HIGGINSON, C</creator><creator>SAVARAJ, N</creator><creator>TAPIERO, H</creator><creator>KOLONIAS, D</creator><creator>LAMPIDIS, T. J</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19921115</creationdate><title>Structural requirements of simple organic cations for recognition by multidrug-resistant cells</title><author>DELLINGER, M ; PRESSMAN, B. C ; CALDERON-HIGGINSON, C ; SAVARAJ, N ; TAPIERO, H ; KOLONIAS, D ; LAMPIDIS, T. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h269t-404fd31dd8bbbd68f417ea419e266aa40564fe5df739f0770d1138539fed28813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>ATP-Binding Cassette, Sub-Family B, Member 1</topic><topic>Biological and medical sciences</topic><topic>Cations - pharmacology</topic><topic>Cell Division - drug effects</topic><topic>Chemical Phenomena</topic><topic>Chemistry, Physical</topic><topic>Drug Resistance - physiology</topic><topic>General aspects</topic><topic>Guanidine</topic><topic>Guanidines - pharmacology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - physiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyridinium Compounds - pharmacology</topic><topic>Structure-Activity Relationship</topic><topic>Tumor Cells, Cultured - drug effects</topic><topic>Verapamil - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DELLINGER, M</creatorcontrib><creatorcontrib>PRESSMAN, B. C</creatorcontrib><creatorcontrib>CALDERON-HIGGINSON, C</creatorcontrib><creatorcontrib>SAVARAJ, N</creatorcontrib><creatorcontrib>TAPIERO, H</creatorcontrib><creatorcontrib>KOLONIAS, D</creatorcontrib><creatorcontrib>LAMPIDIS, T. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DELLINGER, M</au><au>PRESSMAN, B. C</au><au>CALDERON-HIGGINSON, C</au><au>SAVARAJ, N</au><au>TAPIERO, H</au><au>KOLONIAS, D</au><au>LAMPIDIS, T. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structural requirements of simple organic cations for recognition by multidrug-resistant cells</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1992-11-15</date><risdate>1992</risdate><volume>52</volume><issue>22</issue><spage>6385</spage><epage>6389</epage><pages>6385-6389</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>We previously noted that a wide variety of drugs which are recognized by multidrug-resistant cells (MDR+) are positively charged. However, it remains unclear why and how such a large number of structurally different compounds can be distinguished by MDR+ cells. The majority of the diverse compounds subject to MDR are complex and thereby complicate definitive structure/function characterization of the P-glycoprotein-mediated MDR mechanism. Using a series of simple aromatic (alkypyridiniums) and nonaromatic (alkylguanidiniums) organic cations differing in their lipophilicity by stepwise additions of single alkyl carbons, we demonstrate by growth inhibition studies that a single aromatic moiety and a critical degree of lipophilicity (log P > -1) are required for recognition of these simple organic cations by MDR+ cells. Thus, MDR+ cells are not cross-resistant to the nonaromatic guanidiniums but do show cross-resistance to those aromatic pyridiniums with chain lengths > four. Resistance ratios, as determined by comparison of 50% inhibitory doses in MDR- versus MDR+ cells, increase as a function of increasing chain lengths of these latter simple aromatic compounds. Resistance to pyridinium analogues in MDR+ cells is reversible by co-treatment with nontoxic doses of verapamil. Preliminary uptake data with radioactive analogues further implicate the MDR mechanism of lowered drug accumulation in accounting for resistance to the pyridinium homologues. Utilization of these simple organic cations provides a rational basis for better defining the physical chemical properties of more complex compounds processed by the MDR mechanism and suggests a strategy for designing chemotherapeutic agents with reduced susceptibility to MDR.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>1358433</pmid><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-5472 |
ispartof | Cancer research (Chicago, Ill.), 1992-11, Vol.52 (22), p.6385-6389 |
issn | 0008-5472 1538-7445 |
language | eng |
recordid | cdi_proquest_miscellaneous_73283248 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; American Association for Cancer Research |
subjects | Animals Antineoplastic agents ATP-Binding Cassette, Sub-Family B, Member 1 Biological and medical sciences Cations - pharmacology Cell Division - drug effects Chemical Phenomena Chemistry, Physical Drug Resistance - physiology General aspects Guanidine Guanidines - pharmacology Humans Medical sciences Membrane Glycoproteins - physiology Pharmacology. Drug treatments Pyridinium Compounds - pharmacology Structure-Activity Relationship Tumor Cells, Cultured - drug effects Verapamil - pharmacology |
title | Structural requirements of simple organic cations for recognition by multidrug-resistant cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T01%3A36%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structural%20requirements%20of%20simple%20organic%20cations%20for%20recognition%20by%20multidrug-resistant%20cells&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=DELLINGER,%20M&rft.date=1992-11-15&rft.volume=52&rft.issue=22&rft.spage=6385&rft.epage=6389&rft.pages=6385-6389&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E73283248%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73283248&rft_id=info:pmid/1358433&rfr_iscdi=true |